These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 7516415)

  • 41. T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14.
    Seth A; Gote L; Nagarkatti M; Nagarkatti PS
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7877-81. PubMed ID: 1881921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces.
    Tammi R; Paukkonen K; Wang C; Horsmanheimo M; Tammi M
    Arch Dermatol Res; 1994; 286(1):21-9. PubMed ID: 7511363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells.
    Asplund T; Heldin P
    Cancer Res; 1994 Aug; 54(16):4516-23. PubMed ID: 7519123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
    Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activated mouse astrocytes and T cells express similar CD44 variants. Role of CD44 in astrocyte/T cell binding.
    Haegel H; Tölg C; Hofmann M; Ceredig R
    J Cell Biol; 1993 Sep; 122(5):1067-77. PubMed ID: 8354694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The CD44 receptor of lymphoma cells: structure-function relationships and mechanism of activation.
    Rochman M; Moll J; Herrlich P; Wallach SB; Nedvetzki S; Sionov RV; Golan I; Ish-Shalom D; Naor D
    Cell Adhes Commun; 2000 Jan; 7(4):331-47. PubMed ID: 10714394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronan binding identifies the most proliferative activated and memory T cells.
    Maeshima N; Poon GF; Dosanjh M; Felberg J; Lee SS; Cross JL; Birkenhead D; Johnson P
    Eur J Immunol; 2011 Apr; 41(4):1108-19. PubMed ID: 21360702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TABS, a T cell activation antigen that induces LFA-1-dependent aggregation.
    Andrew DP; Yoshino T; Guh L; Martin-Simonet MT; Butcher EC
    J Immunol; 1995 Aug; 155(4):1671-84. PubMed ID: 7543529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
    Yang B; Yang BL; Savani RC; Turley EA
    EMBO J; 1994 Jan; 13(2):286-96. PubMed ID: 7508860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
    Levesque MC; Haynes BF
    J Immunol; 1996 Feb; 156(4):1557-65. PubMed ID: 8568260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs.
    Vogt Sionov R; Naor D
    Int J Cancer; 1997 May; 71(3):462-9. PubMed ID: 9139885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.
    Bartolazzi A; Peach R; Aruffo A; Stamenkovic I
    J Exp Med; 1994 Jul; 180(1):53-66. PubMed ID: 7516417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44 and its interaction with extracellular matrix.
    Lesley J; Hyman R; Kincade PW
    Adv Immunol; 1993; 54():271-335. PubMed ID: 8379464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and function of the CD44 glycoprotein in melanoma cell lines.
    East JA; Mitchell SD; Hart IR
    Melanoma Res; 1993 Oct; 3(5):341-6. PubMed ID: 7507366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of anti-CD44 monoclonal antibody on adhesion of erythroid leukemic cells (ELM-I-1) to hematopoietic supportive cells (MS-5): CD44, but not hyaluronate-mediated, cell-cell adhesion.
    Sugimoto K; Tsurumaki Y; Hoshi H; Kadowaki S; LeBousse-Kerdiles MC; Smadja-Joffe F; Mori KJ
    Exp Hematol; 1994 Jun; 22(6):488-94. PubMed ID: 7514542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1.
    Lesley J; Schulte R; Hyman R
    Exp Cell Res; 1990 Apr; 187(2):224-33. PubMed ID: 2180732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis.
    Verdrengh M; Holmdahl R; Tarkowski A
    Scand J Immunol; 1995 Sep; 42(3):353-8. PubMed ID: 7544911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD44-mediated hyaluronan binding marks proliferating hematopoietic progenitor cells and promotes bone marrow engraftment.
    Lee-Sayer SSM; Dougan MN; Cooper J; Sanderson L; Dosanjh M; Maxwell CA; Johnson P
    PLoS One; 2018; 13(4):e0196011. PubMed ID: 29684048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.